Skip to main content

Heart Conditions clinical trials at UC Davis
2 research studies open to eligible people

  • A Study of the Experimental Device (The AMPLATZER™ Amulet™ Left Atrial Appendage (LAA) Occluder) For Atrial Fibrillation

    open to eligible people ages 18 years and up

    The Amulet™ device will be evaluated for safety and efficacy by demonstrating its performance is non-inferior to the commercially available WATCHMAN® left atrial appendage closure device in patients with non-valvular atrial fibrillation. Patients who are eligible for the trial will be randomized to receive either the Amulet device or the WATCHMAN device and will be followed for 5 years after device implant.

    Sacramento, California and other locations

  • Blood Markers of Stroke and Brain Hemorrhage

    “This study hopes to learn whether there are changes in the genetic material of people who have had a stroke or brain hemorrhage”

    open to eligible people ages 18 years and up

    This study will evaluate whether a gene marker can improve the identification of atrial fibrillation in patients with ischemic stroke, and evaluate whether the decision to anticoagulate could be improved by a marker of atrial fibrillation.

    Sacramento, California

Last updated: